Jifa Li
Impact in
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents
Papers in ⓘ
- Oncology 7
- Cytokine Signaling Pathways and Interactions 6
-
- RNA modifications and cancer 2
- Co-authors
- Lehe Yang (8 shared papers)Xiaoying Huang (5 shared papers)Jichun Tian (2 shared papers)Zhiying Deng (2 shared papers)Youqun Xiang (3 shared papers)Guang Liang (2 shared papers)Xuanxuan Dai (2 shared papers)Lingyuan Xu (2 shared papers)
In The Last Decade
Jifa Li
15 papers receiving 379 citations
Peers
Comparison fields: 5 of 88
- Toxicology 29
- Health Informatics 5
- Pharmacology 28
- Plant Science 114
- Complementary and alternative medicine 24
Countries citing papers authored by Jifa Li
This map shows the geographic impact of Jifa Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jifa Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jifa Li more than expected).
Fields of papers citing papers by Jifa Li
This network shows the impact of papers produced by Jifa Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jifa Li. The network helps show where Jifa Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Jifa Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 74 | |
| 2 | 2017 | 60 | |
| 3 | 2021 | 49 | |
| 4 | 2019 | 45 | |
| 5 | 2022 | 31 | |
| 6 | 2014 | 24 | |
| 7 | 2020 | 18 | |
| 8 | 2021 | 18 | |
| 9 | 2022 | 17 | |
| 10 | 2023 | 14 | |
| 11 | 2021 | 13 | |
| 12 | 2020 | 7 | |
| 13 | 2022 | 6 | |
| 14 | 2024 | 4 | |
| 15 | 2025 | 2 |
About Jifa Li
Jifa Li is a scholar working on Oncology, Molecular Biology, Plant Science, Toxicology and Infectious Diseases, having authored 15 papers that have together received 382 indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (6 papers), Bioactive Compounds and Antitumor Agents (3 papers), Wheat and Barley Genetics and Pathology (2 papers), COVID-19 diagnosis using AI (2 papers), Cancer-related molecular mechanisms research (2 papers), COVID-19 Clinical Research Studies (2 papers), RNA modifications and cancer (2 papers) and Genetics and Plant Breeding (2 papers). The work is most often cited by research in Toxicology (29 citations), Health Informatics (5 citations), Pharmacology (28 citations), Plant Science (114 citations) and Complementary and alternative medicine (24 citations). Jifa Li has collaborated with scholars based in China, Iran and Singapore. Frequent co-authors include Lehe Yang, Xiaoying Huang, Jichun Tian, Zhiying Deng, Youqun Xiang, Guang Liang, Xuanxuan Dai, Lingyuan Xu, Chengguang Zhao and Chengguang Zhao. Their work appears in journals such as IEEE Access, Biochemical and Biophysical Research Communications, Journal of Translational Medicine, Human Vaccines & Immunotherapeutics and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.